Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Viewing Fragmentation through the Disease Triangle: Implications for Pathogen Pressure on Seeds.

Integrative and comparative biology·2025

Same author

Bioaccessibility of Difenoconazole in Rice Following Industry Standard Processing and Preparation Procedures.

Journal of agricultural and food chemistry·2020

Same author

(ICORG 05-03): prospective randomized non-inferiority phase III trial comparing two radiation schedules in malignant spinal cord compression (not proceeding with surgical decompression); the quality of life analysis.

Acta oncologica (Stockholm, Sweden)·2018

Same author

A Phase II Toxicity End Point Trial (ICORG 99-09) of Accelerated Dose-escalated Hypofractionated Radiation in Non-small Cell Lung Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2017

Same author

Accuracy of 64-section MDCT in the diagnosis of cruciate ligament tears.

Clinical radiology·2017

Same author

Predictive value of PI-RADS classification in MRI-directed transrectal ultrasound guided prostate biopsy.

Clinical radiology·2016

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

PET/CT and breast cancer.

C Hegarty¹, C D Collins

¹St. Vincent's University Hospital, Dublin 4, Ireland.

Cancer Imaging : the Official Publication of the International Cancer Imaging Society

|October 1, 2010

Summary

This study reviews the current use of Positron Emission Tomography/Computed Tomography (PET/CT) for breast cancer management. It highlights PET/CT

Area of Science:

Oncology
Nuclear Medicine
Radiology

Background:

Breast cancer diagnosis and staging are critical for effective treatment planning.
Accurate staging relies on advanced imaging techniques to detect primary tumors and metastatic spread.
Positron Emission Tomography/Computed Tomography (PET/CT) offers functional and anatomical imaging capabilities.

Purpose of the Study:

To summarize the current clinical applications and diagnostic performance of PET/CT in breast cancer.
To review the role of PET/CT in staging, treatment response assessment, and recurrence detection.
To discuss the evolving landscape and future directions of PET/CT in breast cancer management.

Main Methods:

Comprehensive literature review of studies evaluating PET/CT in breast cancer.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing ¹⁸F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Experiment Videos

Last Updated: Jun 8, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing ¹⁸F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Analysis of diagnostic accuracy data for various clinical scenarios.

Synthesis of current guidelines and expert opinions on PET/CT utilization.

Main Results:

PET/CT demonstrates significant utility in detecting distant metastases, particularly in high-risk patients.
Its role in initial staging and restaging is increasingly recognized.
PET/CT aids in evaluating treatment response and identifying residual disease.

Conclusions:

PET/CT is a valuable tool in the multidisciplinary management of breast cancer.
Its application continues to expand, improving patient stratification and treatment outcomes.
Further research is warranted to optimize protocols and define its precise role in all stages of breast cancer.